[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BE839362A - Derives de la l-(3,4-dihydroxy-phenyl)-2-methyl-alcaline et leur preparation - Google Patents

Derives de la l-(3,4-dihydroxy-phenyl)-2-methyl-alcaline et leur preparation

Info

Publication number
BE839362A
BE839362A BE164992A BE164992A BE839362A BE 839362 A BE839362 A BE 839362A BE 164992 A BE164992 A BE 164992A BE 164992 A BE164992 A BE 164992A BE 839362 A BE839362 A BE 839362A
Authority
BE
Belgium
Prior art keywords
dihydroxy
phenyl
methyl
preparation
alkaline derivatives
Prior art date
Application number
BE164992A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE839362A publication Critical patent/BE839362A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE164992A 1975-03-12 1976-03-09 Derives de la l-(3,4-dihydroxy-phenyl)-2-methyl-alcaline et leur preparation BE839362A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752510634 DE2510634A1 (de) 1975-03-12 1975-03-12 L-3-(3,4-dihydroxy-phenyl)-2- methyl-alanin-peptide und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BE839362A true BE839362A (fr) 1976-09-09

Family

ID=5941062

Family Applications (1)

Application Number Title Priority Date Filing Date
BE164992A BE839362A (fr) 1975-03-12 1976-03-09 Derives de la l-(3,4-dihydroxy-phenyl)-2-methyl-alcaline et leur preparation

Country Status (23)

Country Link
US (1) US4087520A (fr)
JP (1) JPS51118739A (fr)
AR (1) AR207182A1 (fr)
AT (1) AT349662B (fr)
BE (1) BE839362A (fr)
CA (1) CA1051874A (fr)
CH (1) CH618961A5 (fr)
CS (1) CS193537B2 (fr)
DD (1) DD125548A5 (fr)
DE (1) DE2510634A1 (fr)
DK (1) DK144033C (fr)
ES (1) ES445927A1 (fr)
FR (1) FR2303535A1 (fr)
GB (1) GB1491413A (fr)
HU (1) HU171083B (fr)
IE (1) IE42785B1 (fr)
IT (1) IT1056948B (fr)
LU (1) LU74520A1 (fr)
NL (1) NL7602391A (fr)
PL (1) PL101292B1 (fr)
SE (1) SE408412B (fr)
SU (1) SU656505A3 (fr)
ZA (1) ZA761462B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14064A (en) * 1977-05-06 1981-01-26 Pfizer Phenylgycine derivatives,pharmaceutical compositions and method of use
JPS6026099B2 (ja) * 1977-09-21 1985-06-21 財団法人微生物化学研究会 ペプチド、その酸附加塩およびその製造法
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
US4540683A (en) * 1978-07-31 1985-09-10 Proter S.P.A. In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
US4743590A (en) * 1978-07-31 1988-05-10 Debarbieri Augusto In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
US4740501A (en) * 1978-07-31 1988-04-26 Debarbieri Augusto Interference of b-type retrovirus replication with a tripeptide compound
IT1134503B (it) 1980-11-28 1986-08-13 Proter Spa Composti della diclorodietilaminofenilalanina ad azione antitumorale
JPS5767516A (en) * 1980-09-24 1982-04-24 Microbial Chem Res Found Novel analgesic agent
US4666887A (en) * 1980-11-28 1987-05-19 Proter S.P.A. Intravenous or intraperitoneal administration of a tripeptide compound for treating cancer
US4454065A (en) * 1982-05-18 1984-06-12 Smithkline Beckman Corporation Oligopeptide prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803120A (en) * 1971-09-28 1974-04-09 Hoffmann La Roche Di-and tripeptides of 3-(3,4-dihydroxyphenyl)-alanine
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa

Also Published As

Publication number Publication date
JPS51118739A (en) 1976-10-18
DK144033B (da) 1981-11-23
CS193537B2 (en) 1979-10-31
DD125548A5 (fr) 1977-05-04
IE42785B1 (en) 1980-10-22
SE408412B (sv) 1979-06-11
CA1051874A (fr) 1979-04-03
GB1491413A (en) 1977-11-09
ZA761462B (en) 1977-04-27
NL7602391A (nl) 1976-09-14
ES445927A1 (es) 1977-05-01
SU656505A3 (ru) 1979-04-05
IT1056948B (it) 1982-02-20
PL101292B1 (pl) 1978-12-30
IE42785L (en) 1976-09-12
HU171083B (hu) 1977-11-28
LU74520A1 (fr) 1976-09-01
DE2510634A1 (de) 1976-09-23
DK103876A (da) 1976-09-13
DK144033C (da) 1982-04-26
SE7602135L (sv) 1976-09-13
CH618961A5 (fr) 1980-08-29
US4087520A (en) 1978-05-02
AU1189676A (en) 1977-09-15
AT349662B (de) 1979-04-25
FR2303535A1 (fr) 1976-10-08
ATA180676A (de) 1978-09-15
AR207182A1 (es) 1976-09-15
FR2303535B1 (fr) 1978-11-17

Similar Documents

Publication Publication Date Title
SE432928B (sv) Forfarande for framstellning 4,5,6-trinor-3,7-inter-m-fenylen-pge, och vissa derivat derav
BE859012A (fr) Derives de 4-n-acylfortimicines b, leur preparation et leur application
FR2315930A1 (fr) Derives de 1,4-dihydropyridine et leur procede de preparation
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
BE860736A (fr) Derives de piperidine et leur preparation.
BE839362A (fr) Derives de la l-(3,4-dihydroxy-phenyl)-2-methyl-alcaline et leur preparation
BE843679A (fr) Derives de 16,16-spirocycloalkylprostaglandines, leur preparation et leurs utilisations therapeutiques
FR2330404A1 (fr) Derives de la 1,4-diazepine, leur preparation et leurs utilisations therapeutiques
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
BE844229A (fr) Nouveaux derives d'apovincaminol leur procede de preparation et leur application
SE7609908L (sv) 1,5-dihydro-2h-1,4-bensodiazepin-2-on-derivat och framstellning derav
BE845612A (fr) Derives de tetrazole-5-carboxamide et leur preparation
BE845209A (fr) 1, 1-dichloro-4-methyl-3-hydroxy-pentene-(1) et sa preparation
BE846802A (fr) Composes de 1,3-benzodithiole-2-one et de 1,3-benzodithiole-2-thione, et leur preparation
BE851509A (fr) Derives de piperidine et leur preparation
BE843237A (fr) 1-acyl-1,2,3,4-tetrahydro-6-quinoleinols et leur preparation
BE839035A (fr) Derives de triazolobenzocycloalkylthiadiazine, leur preparation et leur utilisation
BE838802A (fr) Derives de 3-amino-4-carbamyl-pyrrole, leur preparation et leur utilisation
BE843576A (fr) Derives de 1,4-dihydropyridine et leur procede de preparation
BE863092R (fr) Derives de l'argininamide, leur preparation et leurs utilisations therapeutiques
BE840601A (fr) Derives de la chromone, leur preparation et leur utilisation
FR2338942A1 (fr) Derives de 1,3-dihydro-1'-dimethylphosphinylalkyl-3-phenylspiro (isobenzofuranne-cycloazalcanes), leur procede de preparation et leur application
GB1549237A (en) 2,5-dihydrofuron derivatives and their preparation
BE832268A (fr) Derives d'hydrazobenzene et leur preparation.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BIOPHARMA

Effective date: 19950331